Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-23-005444
Filing Date
2023-10-02
Accepted
2023-10-02 16:14:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10823826_13-g.htm SC 13G 103709
  Complete submission text file 0000919574-23-005444.txt   105254
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

EIN.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Subject) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92097 | Film No.: 231299800
SIC: 2836 Biological Products, (No Diagnostic Substances)